Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Med Rep ; 9(6): 2405-10, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24714982

ABSTRACT

It has been demonstrated that connexin 43 (Cx43) and microRNAs have significant roles in glioma. Cyclic adenosine monophosphate (cAMP) is suggested to be a regulator of connexins and microRNAs. However, it remains elusive whether cAMP and exchange protein directly activated by cAMP (Epac2), have a regulatory effect on Cx43 and microRNA-451 (miR-451) in astrocytoma cells. We treated 1321N1 astrocytoma cells with a selective ß2 adrenergic agonist and a selective Epac activator with and without adenyl cyclase and protein kinase A inhibition. Cx43 and miR-451 expression were measured. Next, we evaluated the effect of miR-451 overexpression on Cx43 expression. Cell proliferation was measured using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The results demonstrated that cAMP-Epac2 increased Cx43 and miR-451 expression. However, the alteration of miR-451 expression required a higher dose of drugs. Overexpression of miR-451 had no significant effect on Cx43 expression. The MTT assay showed that cAMP-Epac stimulation and miR-451 overexpression had a synergic inhibitory effect on cell proliferation. These findings may expand our understanding of the molecular biology of glioma and provide new potential therapeutic targets.


Subject(s)
Adrenergic beta-2 Receptor Agonists/pharmacology , Connexin 43/genetics , Cyclic AMP/metabolism , Gene Expression Regulation/drug effects , Guanine Nucleotide Exchange Factors/metabolism , MicroRNAs/genetics , Astrocytoma/genetics , Astrocytoma/metabolism , Cell Line, Tumor , Cell Proliferation , Gene Expression , Guanine Nucleotide Exchange Factors/genetics , Humans , RNA, Messenger/genetics , Receptors, Adrenergic, beta-2/metabolism , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...